Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21038 | 375 | 39.4 | 73% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FAT10 | Author keyword | 59 | 90% | 7% | 26 |
| 2 | MALLORY BODY | Author keyword | 7 | 44% | 3% | 12 |
| 3 | MALLORY DENK BODIES MDBS | Author keyword | 6 | 80% | 1% | 4 |
| 4 | MALLORY BODIES | Author keyword | 6 | 40% | 3% | 12 |
| 5 | P62 | Author keyword | 4 | 10% | 10% | 38 |
| 6 | UBIQUITIN D | Author keyword | 3 | 57% | 1% | 4 |
| 7 | FATYLATION | Author keyword | 3 | 100% | 1% | 3 |
| 8 | NUB1L | Author keyword | 2 | 67% | 1% | 2 |
| 9 | DIUBIQUITIN | Author keyword | 2 | 50% | 1% | 3 |
| 10 | SEQUESTOSOME | Author keyword | 2 | 40% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FAT10 | 59 | 90% | 7% | 26 | Search FAT10 | Search FAT10 |
| 2 | MALLORY BODY | 7 | 44% | 3% | 12 | Search MALLORY+BODY | Search MALLORY+BODY |
| 3 | MALLORY DENK BODIES MDBS | 6 | 80% | 1% | 4 | Search MALLORY+DENK+BODIES+MDBS | Search MALLORY+DENK+BODIES+MDBS |
| 4 | MALLORY BODIES | 6 | 40% | 3% | 12 | Search MALLORY+BODIES | Search MALLORY+BODIES |
| 5 | P62 | 4 | 10% | 10% | 38 | Search P62 | Search P62 |
| 6 | UBIQUITIN D | 3 | 57% | 1% | 4 | Search UBIQUITIN+D | Search UBIQUITIN+D |
| 7 | FATYLATION | 3 | 100% | 1% | 3 | Search FATYLATION | Search FATYLATION |
| 8 | NUB1L | 2 | 67% | 1% | 2 | Search NUB1L | Search NUB1L |
| 9 | DIUBIQUITIN | 2 | 50% | 1% | 3 | Search DIUBIQUITIN | Search DIUBIQUITIN |
| 10 | SEQUESTOSOME | 2 | 40% | 1% | 4 | Search SEQUESTOSOME | Search SEQUESTOSOME |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROTEIN FAT10 | 30 | 100% | 3% | 12 |
| 2 | PHOSPHOTYROSINE INDEPENDENT LIGAND | 30 | 69% | 7% | 25 |
| 3 | DRUG PRIMED MICE | 29 | 77% | 5% | 20 |
| 4 | GRISEOFULVIN TREATED MICE | 15 | 67% | 4% | 14 |
| 5 | MODIFIER FAT10 | 15 | 88% | 2% | 7 |
| 6 | MALLORY BODY FORMATION | 8 | 42% | 4% | 15 |
| 7 | FAT10 | 7 | 53% | 3% | 10 |
| 8 | GRISEOFULVIN TREATED MOUSE | 6 | 80% | 1% | 4 |
| 9 | PRIMED MOUSE LIVER | 6 | 80% | 1% | 4 |
| 10 | MALLORY BODIES | 4 | 20% | 5% | 18 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| FAT10ylation as a signal for proteasomal degradation | 2014 | 6 | 47 | 57% |
| The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model | 2011 | 8 | 33 | 64% |
| Sequestosome 1/p62: across diseases | 2012 | 22 | 67 | 27% |
| Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease | 2012 | 24 | 112 | 23% |
| From Mallory to Mallory-Denk bodies: what, how and why? | 2007 | 68 | 126 | 42% |
| Alcoholic cholangitis as a variant alcoholic disease of the liver (case report and review of the literature) | 2005 | 0 | 3 | 100% |
| Structure and functional properties of the ubiquitin binding protein p62 | 2002 | 125 | 43 | 37% |
| THE MALLORY BODY - MORPHOLOGICAL, CLINICAL AND EXPERIMENTAL STUDIES - LITERATURE SURVEY .1. | 1994 | 58 | 124 | 35% |
| Mallory bodies revisited | 2000 | 87 | 93 | 32% |
| P62 and the sequestosome, a novel mechanism for protein metabolism | 1998 | 73 | 26 | 19% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOTECHNOL THURGAU | 1 | 17% | 2.1% | 8 |
| 2 | PROGRAM CELLULAR MOL BIOSCI | 1 | 20% | 1.1% | 4 |
| 3 | LOS ANGELES BIOMED LA BIOMED | 1 | 50% | 0.3% | 1 |
| 4 | ROLLINS 5001 | 1 | 50% | 0.3% | 1 |
| 5 | EXCELLENCECARDIOVASC | 0 | 33% | 0.3% | 1 |
| 6 | TEAM MOL MISREADING | 0 | 33% | 0.3% | 1 |
| 7 | MED 2 GASTROENTEROL | 0 | 25% | 0.3% | 1 |
| 8 | MED REGULAT NEURONAL CELL EXCITABIL | 0 | 25% | 0.3% | 1 |
| 9 | LIVER DIS GASTROENTEROL LIVER DIS | 0 | 20% | 0.3% | 1 |
| 10 | MICROBICIDE TRIALS NETWORK | 0 | 20% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000145799 | PAI 1 TRANSCRIPTION//MICROBIOL IMMUNOL MOL GENET A68//ANTITUMOR STUDY |
| 2 | 0.0000130800 | PACHYONYCHIA CONGENITA//EPIDERMOLYSIS BULLOSA SIMPLEX//EPIDERMOLYTIC HYPERKERATOSIS |
| 3 | 0.0000102266 | INTERMEDIATE FILAMENTS//CYTOKERATINS//INTERMEDIATE FILAMENT |
| 4 | 0.0000090673 | ALCOHOLEMIA//ALCOHOL UTILIZATION//ELDERLY CADAVERS |
| 5 | 0.0000089116 | ALCOHOLIC LIVER DISEASE//ALCOHOLIC HEPATITIS//HEPATOBIOL TOXICOL |
| 6 | 0.0000088663 | DSK2//UBIQUILIN 1//LUBAC |
| 7 | 0.0000081755 | ISG15//ISGYLATION//HERC5 |
| 8 | 0.0000076242 | PUPYLATION//PROKARYOTIC UBIQUITIN LIKE PROTEIN//URM1 |
| 9 | 0.0000062141 | INDIAN CHILDHOOD CIRRHOSIS//NORTH RONALDSAY SHEEP//MALLORY HYALINE |
| 10 | 0.0000054669 | LIVER DIS UNIT//CYP 2B1 2//ETHANOL CONTAINING DIET |